Hugh E. Black, DVM, Ph.D. |
Preclinical (Safety) |
Christian G. Bradley |
Regulatory Compliance (GMP) |
Matthews O. Bradley, Ph.D. |
Preclinical (Disease Models) |
Charlie Brindley,Ph.D. |
Pharmacokinetics |
Guy Buckley |
Patents |
S. Barak Caine,Ph.D. |
Drug Dependency |
Joyce Chiarenza |
Labeling and Promotional Materials |
Debbie R. Cosgrove |
Regulatory Compliance (GCP) |
Roger Croswell, Ph.D. |
Regulatory Strategy |
Nicola Giacona Dahl, PharmD |
Clinical (Medical Writer) |
Lynne Douglas |
Clinical Trial Management, Data Management and Biostatistics |
Richard G. Einig, Ph.D. |
Regulatory Compliance (GMP) |
Julia Elenbaas, PharmD |
Clinical (Medical Writer) |
Robert Fowler, M.D. |
Clinical (Safety) |
H. Guenter Hennings, Ph.D. |
Regulatory (EU) |
Anthony J. Japour, M.D. |
Clinical (Antivirals) |
Karen Jervis, Ph.D. |
IP Management and Product Licensing (Biotech) |
| Paul Johnston, Ph.D. |
CMC (Drug Product & Drug Substance – Biotech) |
Norman Lavy, M.D. |
Regulatory (US) |
Anthony Lockett, M.D., Ph.D. |
Clinical (Vaccines) |
Fiona MacLeod, BS |
Regulatory (EU and US) |
David Madge, Ph.D. |
Medicinal Chemistry |
Carol Maxwell |
Pharmacovigilance |
Ross Maxwell, Ph.D. |
Medical Devices |
| Bernard Olsen, Ph.D. |
Chemistry, Manufacturing and Control |
Benard Rushton BVMS, Ph.D., MRCVS, FRCPath |
Toxicology/Pathology |
Richard Salvador, Ph.D. |
Preclinical (Pharmacology) |
Herbert Syrowatka, Ph.D. |
Regulatory Compliance (GMP) |
Thomas N. Thompson, Ph.D. |
Preclinical (ADME) |
William Jay Treat, Ph.D. |
CMC (API-Biologicals) |
Mary Treat, MS |
Regulatory Compliance (GMP) |
David Tweats, Prof., Ph.D., FRCPath, FIBios |
Genotoxicity |
Laurene Wang-Smith, Ph.D. |
Clinical (ADME) |
Adrian Weiss, M.D. |
Clinical (Oncology) |
| Jeffrey Wilson, Ph.D. |
CMC |
|
|